Abivax logo

Abivax

ABVX | NASDAQ
Chart Builder DCF Calculator
$83.61
-$3.97 (-4.53%)
At close: Nov 16, 2026, 4:00 PM ET
$83.90
+$0.29 (+0.35%)
After-hours: Nov 16, 2026, 7:58 PM ET
-4.53%

Rating

Updated: Nov 16, 2026
36.6
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #625/1021 (Top 61%)

Key Statistics

Market Data

Market Cap $7.31B
1D Range
82.62 88.17
52W Range
72.50 145.31

Valuation (TTM)

PE -20.08
PB 17.47
EV/EBITDA -15.81

Valuation (NTM)

Forward PE N/A
Forward PEG 2.85
Price Target $156.50
Loading financial charts...

Profile

Abivax S.A., operating as ABIVAX Société Anonyme, is a French pharmaceutical firm focused on the discovery and optimization of therapeutic drugs for inflammatory, infectious, and oncological diseases....

Sector Healthcare
Industry Biotechnology
Employees 80
IPO Date Oct 20, 2023
Fiscal Year January - December

Latest News

Abivax to Participate in Upcoming Fall Investor Conferences

14 days ago · globenewswire.com

Abivax to Participate in Upcoming Fall Investor Conferences
Cedar Grove Capital Q3 2026 Portfolio Update

1 month ago · seekingalpha.com

Cedar Grove Capital Q3 2026 Portfolio Update
Abivax: Priced Right Ahead Of 2 Make-Or-Break Catalysts

2 months ago · seekingalpha.com

Abivax: Priced Right Ahead Of 2 Make-Or-Break Catalysts

2 months ago · benzinga.com

These Analysts Slash Their Forecasts On Abivax Following H1 Results

2 months ago · globenewswire.com

Abivax Presents Business Updates and First Half 2026 Financial Results
Accenture, Abivax and 3 Stocks to Watch Heading Into Monday

2 months ago · benzinga.com

Accenture, Abivax and 3 Stocks to Watch Heading Into Monday
4 Biotech Stocks to Watch as Potential Takeover Targets

2 months ago · zacks.com

4 Biotech Stocks to Watch as Potential Takeover Targets
Abivax Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

2 months ago · benzinga.com

Abivax Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Abivax SA Sponsored ADR (ABVX) Upgraded to Buy: Here's Why

2 months ago · zacks.com

Abivax SA Sponsored ADR (ABVX) Upgraded to Buy: Here's Why
Abivax: Obefazimod Goes The Distance And So Does My Buy Rating

4 months ago · seekingalpha.com

Abivax: Obefazimod Goes The Distance And So Does My Buy Rating

Earnings

Next Earnings
Dec 21, 2026
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
10
Consensus
Buy
Price Target
$156.50
Upside
+87.18%
Buy (9)
Hold (1)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.